Qiaojun Fang

21PUBLICATIONS
37CO-AUTHORS
Nuclear physicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiomaterialsOrganometallic chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 23, 2026
Multivalent Peptide-Guided EZH2 Degradation Sensitizes Immune Checkpoint Therapy in TNBC.

Minxian Li, Haipeng Zhao, Lilusi Ma

|Jan 23, 2026
Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer.

Mengting Chen, Xiangyu Chu, Haipeng Zhao

|Jun 17, 2024
A Proactive Intervention Study in Metabolic Syndrome High-Risk Populations Using Phenome-Based Actionable P4 Medicine Strategy.

Qiongrong Huang, Zhiyuan Hu, Qiwen Zheng

Pageof 4